Home › Free Stock Grades › BHVN
Biohaven Ltd. (BHVN) Stock Grade
BHVN · Healthcare
A-
Market Cap
$1.2B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Biohaven Ltd.'s fundamentals
Biohaven Ltd. is a biotechnology company with a market capitalization of $1.2 billion that is not yet profitable, as evidenced by its latest annual statement showing a net loss and a net margin of 0.0%. The company generated no year-over-year revenue growth, indicating flat sales performance in its most recent reporting period. The company does not currently pay a dividend to shareholders. Traditional profitability metrics like P/E ratio and return on equity are not applicable given the company's loss-making status.